We plan, organise and realise customised preclinical studies for life science companies and academic institutions.
For more than 15 years 120+ satisfied customers rely on our expertise, our experience and particularly on our passion for quality. In February 2017, Pharmacelsus joined the GBA Group Pharma.
Hit-to-Lead & Lead Optimisation
The Pharmacelsus portfolio covers the complete drug discovery and development testing program for small molecules in vitro, ex vivo as well as G(C)LP and non-GLP bioanalysis. Our assays meet regulatory demands.